LCDX Stock: Caliber Imaging & Diagnostics, Inc. Stock Price, Analysis & Insights
Get live LCDX stock price $0.00, comprehensive Caliber Imaging & Diagnostics, Inc. stock analysis, charts, news, and expert forecast. Real-time LCDX stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a r...
Company Information
- CEO
- L. Michael Hone
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 28
Contact Information
- Website
- https://www.caliberid.com
- Address
- 100 Burtt Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.45) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Caliber Imaging & Diagnostics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Caliber Imaging & Diagnostics, Inc.
- ⚠Investors should consider how Caliber Imaging & Diagnostics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
5.10K
P/E Ratio (TTM)
-0.02
Beta
0.45
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LCDX with peer companies:
- Price
- $0.00
- Market cap
- 3.35K
- Price
- $0.00
- Market cap
- 6.85K
- Price
- $0.00
- Market cap
- 2.31K
- Price
- $0.00
- Market cap
- 8.07K
- Price
- $0.00
- Market cap
- 26.37K
- Price
- $0.00
- Market cap
- 3.31K
- Price
- $0.00
- Market cap
- 3.21K
- Price
- $0.00
- Market cap
- 2.18K
- Price
- $0.30
- Market cap
- 5.33M
- Price
- $0.00
- Market cap
- 2.15K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.